Hong Kong

Last Updated 16 April 2021.

2 Vaccines Approved for Use in Hong Kong

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 82 countries

  17 trials in 12 countries

  RNA

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 22 countries

  14 trials in 7 countries

  Inactivated

4 Vaccines in Clinical Trials in Hong Kong

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 82 countries

  17 trials in 12 countries

  RNA

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 91 other countries

  24 trials in 15 countries

  Non Replicating Viral Vector

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 22 countries

  14 trials in 7 countries

  Inactivated

• The University of Hong Kong
  DelNS1-nCoV-RBD LAIV

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Live-Attenuated